131 related articles for article (PubMed ID: 11775539)
21. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC).
Hiscott P; Hagan S; Heathcote L; Sheridan CM; Groenewald CP; Grierson I; Wong D; Paraoan L
Eye (Lond); 2002 Jul; 16(4):393-403. PubMed ID: 12101446
[TBL] [Abstract][Full Text] [Related]
22. [Mitogenesis of platelet-derived growth factors to human osteoblasts modulated by basic fibroblast growth factor].
Chen J; Yang D; Jing Z; Wu D; Ding H; Jin D
Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):707-10. PubMed ID: 11832146
[TBL] [Abstract][Full Text] [Related]
23. PDGF receptors are activated in human epiretinal membranes.
Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
25. The impact of tacrolimus on growth factors in experimental proliferative vitreoretinopathy.
Turgut B; Uyar F; Ustundag B; Celiker U; Akpolat N; Demir T
Retina; 2012 Feb; 32(2):232-41. PubMed ID: 21934553
[TBL] [Abstract][Full Text] [Related]
26. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
Liang Y; Li X; Fan J; Zhao M; Jiang Y
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases].
Cao J; Wu L; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957
[TBL] [Abstract][Full Text] [Related]
28. Association between telomerase activity and basic fibroblast growth factor up-regulation in retinoblastomas.
Kondo Y; Tanaka Y; Shields JA; Kondo S
Anticancer Res; 2001; 21(6A):3765-72. PubMed ID: 11911245
[TBL] [Abstract][Full Text] [Related]
29. Tenascin and decorin in epiretinal membranes of proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Hagedorn M; Esser P; Wiedemann P; Heimann K
Ger J Ophthalmol; 1993 Feb; 2(1):28-31. PubMed ID: 7679595
[TBL] [Abstract][Full Text] [Related]
30. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
[TBL] [Abstract][Full Text] [Related]
31. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy.
Cui JZ; Chiu A; Maberley D; Ma P; Samad A; Matsubara JA
Eye (Lond); 2007 Feb; 21(2):200-8. PubMed ID: 16531976
[TBL] [Abstract][Full Text] [Related]
32. [Ultrastructural characteristics of epiretinal membranes].
Wang F; Yan Y; Zhang X; Cai W
Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):440-2, 24. PubMed ID: 11835856
[TBL] [Abstract][Full Text] [Related]
33. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
34. Quantitative study of basic fibroblast growth factor in vitreous with proliferative vitreoretinopathy.
Liang X; Li C; Gao R; Ding X; Tang S; Xie C; Li S
Yan Ke Xue Bao; 2000 Mar; 16(1):7-10. PubMed ID: 12579721
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor and fibroblast growth factor 5 are colocalized in vascular and avascular epiretinal membranes.
Schneeberger SA; Hjelmeland LM; Tucker RP; Morse LS
Am J Ophthalmol; 1997 Oct; 124(4):447-54. PubMed ID: 9323936
[TBL] [Abstract][Full Text] [Related]
36. [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases].
Heidenkummer HP; Kampik A
Fortschr Ophthalmol; 1991; 88(3):219-24. PubMed ID: 1889766
[TBL] [Abstract][Full Text] [Related]
37. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker.
Armstrong D; Augustin AJ; Spengler R; Al-Jada A; Nickola T; Grus F; Koch F
Ophthalmologica; 1998; 212(6):410-4. PubMed ID: 9787233
[TBL] [Abstract][Full Text] [Related]
38. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
[TBL] [Abstract][Full Text] [Related]
39. Growth factors outside the PDGF family drive experimental PVR.
Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
